RAFFI ASADORIAN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RAFFI ASADORIAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RAFFI ASADORIAN. RAFFI ASADORIAN is a Chief Financial Officer in AMYRIS, INC. ($AMRS) and a Chief Financial Officer in ACELRX PHARMACEUTICALS INC ($ACRX).
Address: C/O AMYRIS, INC. 5885 HOLLIS STREET, SUITE 100 EMERYVILLE 94608 CA
Companies in which RAFFI ASADORIAN is an Insider
ACELRX PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RAFFI ASADORIAN: Chief Financial Officer
Holdings: 260,597 shares
Current Value: $781,791
Latest Transaction: Mar 05 2021
$ACRX Market Capitalization: $131.47M
$ACRX Previous Close: $3.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AMYRIS, INC.
Industry: INDUSTRIAL ORGANIC CHEMICALS [2860]
Position of RAFFI ASADORIAN: Chief Financial Officer
Holdings: 241,648 shares
Current Value: $123,240
Latest Transaction: Jan 04 2017
$AMRS Market Capitalization: $136.77M
$AMRS Previous Close: $0.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of RAFFI ASADORIAN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Option Exercise | A | 1.88 | 68,750 | 129,250 | 68,750 | |
| Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Option Exercise | A | 1.88 | 137,500 | 258,500 | 137,500 | |
| Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Grant | A | 0.00 | 68,750 | 0 | 260,597 | 191.8 K to 260.6 K (+35.84 %) |
| Feb 12 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Payment of Exercise | F | 2.63 | 9,024 | 23,733 | 183,299 | 192.3 K to 183.3 K (-4.69 %) |
| Feb 09 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Payment of Exercise | F | 2.59 | 9,414 | 24,382 | 192,323 | 201.7 K to 192.3 K (-4.67 %) |
| Feb 13 2020 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Payment of Exercise | F | 1.71 | 7,924 | 13,550 | 188,765 | 196.7 K to 188.8 K (-4.03 %) |
| Feb 07 2020 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Option Exercise | A | 1.72 | 137,500 | 236,500 | 137,500 |